N-Butyldeoxynojirimycin
SIGMA/B8299 - film (dried in situ)
Synonym: Miglustat; NB-DNJ
CAS Number: 72599-27-0
Empirical Formula (Hill Notation): C10H21NO4
Molecular Weight: 219.28
MDL Number: MFCD00272581
Linear Formula: C10H21NO4
Product Type: Chemical
| assay | ≥98% (TLC) |
| form | film (dried in situ) |
| InChI | 1S/C10H21NO4/c1-2-3-4-11- |
| InChI key | UQRORFVVSGFNRO-UTINFBMNSA |
| Quality Level | 200 ![]() |
| SMILES string | CCCCN1C[C@H](O)[C@@H](O)[ |
| solubility | water: 9.80-10.20 mg/mL, clear, colorless |
| storage temp. | 2-8°C |
| Application: | N-Butyldeoxynojirimycin has been used: • in the inhibition of glycolipid synthesis in neuroblastoma cells • in the inhibition the ceramide-specific glycosyltransferase in hepatocytes • in the inhibition of β-glucosidase (GBA2) using fluorescence- activity assay in human embryonic kidney (HEK293) cells. |
| Biochem/physiol Actions: | α-glucosidase Inhibitor |
| Biochem/physiol Actions: | N-Butyldeoxynojirimycin is an inhibitor of glucosyltransferase and α-glucosidases. N-Butyldeoxynojirimycin, also known as misglustat, reduces glycolipid levels by substrate reduction therapy (SRT) and is effectively used for the treatment of glycosphingolipid lysosomal storage disorder, Gaucher disease. |
| General description: | N-Butyldeoxynojirimycin is an alkylated product of imino sugar deoxynojirimycin. |
| Packaging: | 1, 5 mg in glass bottle |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (TLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |

